Ken Fisher’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.35M Sell
88,392
-3,998
-4% -$308K ﹤0.01% 443
2025
Q4
$7.33M Buy
92,390
+3,291
+4% +$259K ﹤0.01% 426
2025
Q3
$6.72M Sell
89,099
-5,016
-5% -$344K ﹤0.01% 442
2025
Q2
$6.49M Buy
94,115
+955
+1% +$62.6K ﹤0.01% 451
2025
Q1
$6.31M Buy
93,160
+11,599
+14% +$694K ﹤0.01% 466
2024
Q4
$3.66M Buy
81,561
+8,004
+11% +$449K ﹤0.01% 526
2024
Q3
$4.63M Sell
73,557
-146
-0.2% -$8.52K ﹤0.01% 495
2024
Q2
$4.35M Buy
73,703
+2,603
+4% +$163K ﹤0.01% 503
2024
Q1
$5.67M Buy
71,100
+3,240
+5% +$247K ﹤0.01% 493
2023
Q4
$5.36M Sell
67,860
-1,372
-2% -$97.6K ﹤0.01% 484
2023
Q3
$4.83M Buy
69,232
+2,352
+4% +$167K ﹤0.01% 531
2023
Q2
$4.62M Buy
66,880
+1,628
+2% +$116K ﹤0.01% 554
2023
Q1
$4.85M Sell
65,252
-7,579
-10% -$636K ﹤0.01% 550
2022
Q4
$6.79M Buy
72,831
+1,647
+2% +$159K ﹤0.01% 504
2022
Q3
$6.79M Sell
71,184
-1,012
-1% -$100K 0.01% 441
2022
Q2
$6.69M Buy
72,196
+4,416
+7% +$431K ﹤0.01% 391
2022
Q1
$6.86M Buy
67,780
+5,141
+8% +$540K ﹤0.01% 414
2021
Q4
$6.46M Buy
62,639
+910
+1% +$84.1K ﹤0.01% 430
2021
Q3
$5.24M Buy
61,729
+3,600
+6% +$302K ﹤0.01% 426
2021
Q2
$4.85M Sell
58,129
-1,793
-3% -$147K ﹤0.01% 435
2021
Q1
$4.51M Buy
59,922
+445
+0.7% +$32.4K ﹤0.01% 441
2020
Q4
$4.06M Buy
59,477
+9,912
+20% +$645K ﹤0.01% 439
2020
Q3
$2.9M Buy
49,565
+3,852
+8% +$240K ﹤0.01% 443
2020
Q2
$2.97M Buy
45,713
+39,828
+677% +$2.51M ﹤0.01% 441
2020
Q1
$349K Sell
5,885
-10,652
-64% -$711K ﹤0.01% 661
2019
Q4
$1.23M Buy
16,537
+1,628
+11% +$114K ﹤0.01% 557
2019
Q3
$940K Sell
14,909
-967
-6% -$57.3K ﹤0.01% 617
2019
Q2
$865K Sell
15,876
-2,277
-13% -$123K ﹤0.01% 612
2019
Q1
$979K Buy
18,153
+1,042
+6% +$64.3K ﹤0.01% 585
2018
Q4
$1.12M Buy
17,111
+62
+0.4% +$4.63K ﹤0.01% 586
2018
Q3
$1.34M Sell
17,049
-300,626
-95% -$21.5M ﹤0.01% 561
2018
Q2
$20.4M Buy
317,675
+17,250
+6% +$1.14M 0.03% 285
2018
Q1
$18.7M Buy
300,425
+67,079
+29% +$4.81M 0.02% 288
2017
Q4
$16.9M Sell
233,346
-27,676
-11% -$2.01M 0.02% 297
2017
Q3
$21.2M Buy
261,022
+1,344
+0.5% +$106K 0.03% 268
2017
Q2
$20.9M Sell
259,678
-3,511
-1% -$277K 0.03% 265
2017
Q1
$20.7M Buy
263,189
+128,272
+95% +$10.2M 0.03% 246
2016
Q4
$10.6M Buy
134,917
+2,176
+2% +$176K 0.02% 293
2016
Q3
$11.8M Buy
132,741
+2,958
+2% +$279K 0.02% 287
2016
Q2
$12.6M Sell
129,783
-12,541
-9% -$1.25M 0.02% 279
2016
Q1
$14.6M Buy
142,324
+20,016
+16% +$1.95M 0.03% 268
2015
Q4
$12M Sell
122,308
-497
-0.4% -$48.7K 0.02% 281
2015
Q3
$11.8M Sell
122,805
-33,632
-21% -$3.54M 0.02% 275
2015
Q2
$16.4M Sell
156,437
-2,538
-2% -$259K 0.03% 250
2015
Q1
$16.4M Buy
158,975
+16,939
+12% +$1.71M 0.03% 250
2014
Q4
$13.7M Buy
142,036
+1,282
+0.9% +$113K 0.03% 257
2014
Q3
$11.2M Sell
140,754
-14,611
-9% -$1.15M 0.02% 263
2014
Q2
$11.7M Buy
155,365
+67,257
+76% +$5.08M 0.02% 257
2014
Q1
$6.6M Sell
88,108
-56,551
-39% -$3.99M 0.01% 290
2013
Q4
$10.4M Sell
144,659
-2,580
-2% -$166K 0.02% 262
2013
Q3
$8.36M Sell
147,239
-11,445
-7% -$682K 0.02% 271
2013
Q2
$9.07M Buy
+158,684
New +$9.19M 0.02% 254

Other funds holding CVS

Ken Fisher's CVS Position: Q1 2026 in Review

Ken Fisher reduced its CVS Health (CVS) stake by 4.3% in Q1 2026, selling an estimated $308K and leaving 88,392 shares worth $6.35M. The position accounts for ﹤0.01% of the portfolio, ranked #443.

Ken Fisher first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.2M in Q3 2017. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Ken Fisher held 88,392 shares of CVS Health worth $6.35M as of Q1 2026.
  • Ken Fisher sold 3,998 CVS Health shares in Q1 2026, an estimated $308K.
  • CVS Health made up ﹤0.01% of Ken Fisher's portfolio in Q1 2026, its #443 holding.
  • Ken Fisher first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Ken Fisher's CVS Health position peaked at $21.2M in Q3 2017.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.